Folgen
Ming Tsao
Ming Tsao
University of Toronto, University Health Network, Princess Margaret Cancer Centre
Bestätigte E-Mail-Adresse bei uhn.ca
Titel
Zitiert von
Zitiert von
Jahr
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma
WD Travis, E Brambilla, M Noguchi, AG Nicholson, KR Geisinger, ...
Journal of thoracic oncology 6 (2), 244-285, 2011
61672011
The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification
WD Travis, E Brambilla, AG Nicholson, Y Yatabe, JHM Austin, ...
Journal of thoracic oncology 10 (9), 1243-1260, 2015
48752015
Comprehensive molecular profiling of lung adenocarcinoma
Cancer Genome Atlas Research Network
Nature 511 (7511), 543, 2014
4853*2014
The landscape of somatic copy-number alteration across human cancers
R Beroukhim, CH Mermel, D Porter, G Wei, S Raychaudhuri, J Donovan, ...
Nature 463 (7283), 899-905, 2010
44402010
The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer
P Goldstraw, K Chansky, J Crowley, R Rami-Porta, H Asamura, ...
Journal of Thoracic Oncology 11 (1), 39-51, 2016
43802016
Comprehensive genomic characterization of squamous cell lung cancers
CGAR Network
Nature 489 (7417), 519-25, 2012
37932012
Vinorelbine plus cisplatin vs. observation in resected non–small-cell lung cancer
T Winton, R Livingston, D Johnson, J Rigas, M Johnston, C Butts, ...
New England Journal of Medicine 352 (25), 2589-2597, 2005
23442005
Erlotinib in lung cancer—molecular and clinical predictors of outcome
MS Tsao, A Sakurada, JC Cutz, CQ Zhu, S Kamel-Reid, J Squire, ...
New England Journal of Medicine 353 (2), 133-144, 2005
23202005
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
AV Biankin, N Waddell, KS Kassahn, MC Gingras, LB Muthuswamy, ...
Nature 491 (7424), 399-405, 2012
22572012
Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
KP Hoeflich, J Luo, EA Rubie, MS Tsao, OU Jin, JR Woodgett
Nature 406 (6791), 86-90, 2000
18272000
Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: guideline from the College of American …
NI Lindeman, PT Cagle, DL Aisner, ME Arcila, MB Beasley, EH Bernicker, ...
Archives of pathology & laboratory medicine 142 (3), 321-346, 2018
16122018
Probability of cancer in pulmonary nodules detected on first screening CT
A McWilliams, MC Tammemagi, JR Mayo, H Roberts, G Liu, K Soghrati, ...
New England journal of medicine 369 (10), 910-919, 2013
14042013
PD-L1 immunohistochemistry assays for lung cancer: results from phase 1 of the blueprint PD-L1 IHC assay comparison project
FR Hirsch, A McElhinny, D Stanforth, J Ranger-Moore, M Jansson, ...
Journal of Thoracic Oncology 12 (2), 208-222, 2017
13222017
Characterizing the cancer genome in lung adenocarcinoma
BA Weir, MS Woo, G Getz, S Perner, L Ding, R Beroukhim, WM Lin, ...
Nature 450 (7171), 893-898, 2007
12972007
Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas
JD Campbell, A Alexandrov, J Kim, J Wala, AH Berger, CS Pedamallu, ...
Nature genetics 48 (6), 607-616, 2016
11992016
Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study
Nature medicine 14 (8), 822-827, 2008
11462008
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
AJ Bass, H Watanabe, CH Mermel, S Yu, S Perner, RG Verhaak, SY Kim, ...
Nature genetics 41 (11), 1238-1242, 2009
10932009
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
DB Doroshow, S Bhalla, MB Beasley, LM Sholl, KM Kerr, S Gnjatic, ...
Nature reviews Clinical oncology 18 (6), 345-362, 2021
10182021
EGFR mutations and lung cancer
G da Cunha Santos, FA Shepherd, MS Tsao
Annual Review of Pathology: Mechanisms of Disease 6 (1), 49-69, 2011
9722011
An overview of the c-MET signaling pathway
SL Organ, MS Tsao
Therapeutic advances in medical oncology 3 (1_suppl), S7-S19, 2011
9672011
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20